Clinical trial results have shown that the D2 receptor was highly expressed on the surface of pituitary adenoma cells and its stem cells in patients with pituitary adenoma with a significant secretion of PRL [14, 15]. This evidence concerns the gene PRL and pituitary gland adenoma.